Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Raloxifene Reduces Risk of Endometrial Cancer
Link ID 9134
Title Raloxifene Reduces Risk of Endometrial Cancer
Url http://www.medscape.com/viewarticle/581068?src=rss
Description While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene also appears to lower the odds of developing endometrial cancer, researchers report in the September 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Sep 27, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Etanercept Has Benefits in Early Active Ankylosing Spondylitis
  The TNF inhibitor etanercept (Enbrel; Pfizer) may be more effective than sulfasalazine for early active ankylosing spondylitis (AS), results of a large randomized trial suggest. Reuters Health Information
Category:   Articles > Pharmacists


2. Can Genes Predict Response to Antipsychotics?Can Genes Predict Response to Antipsychotics?
  Some commonalities of predictors of response to iloperidone and risperidone from a study done by the manufacturer of olanzapine Medscape Psychiatry
Category:   Articles > Pharmacists


3. High-Impact Sports May Increase Fracture Risk in Teen Girls
  High-impact physical activity in adolescent girls, especially basketball, running, and gymnastics/cheerleading, may increase the risk for stress fractures. Medscape Medical News
Category:   Articles > Pharmacists


4. Managing Pain: Determining the Right Maintenance DoseManaging Pain: Determining the Right Maintenanc
  Once severe pain is under control, how can you then find the right maintenance dose to keep this person out of pain? Dr. von Gunten offers practical, clinical advice. The Institute for Palliative Medicine
Category:   Articles > Pharmacists


5. Bevacizumab Plus Paclitaxel Does Not Prolong Overall Survival in Metastatic Breast Cancer
  Adding bevacizumab to paclitaxel did not prolong overall survival in women with metastatic breast cancer, but it did prolong progression-free survival when given as an initial therapy. Medscape Medical News
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS